4.8 Article

Inhibition of IFN-γ signaling by an Epstein-Barr virus immediate-early protein

Journal

IMMUNITY
Volume 15, Issue 5, Pages 787-799

Publisher

CELL PRESS
DOI: 10.1016/S1074-7613(01)00226-6

Keywords

-

Categories

Funding

  1. NCI NIH HHS [P01-CA19014, 2-R01-CA58853, 2-R01-CA66519] Funding Source: Medline
  2. NIAID NIH HHS [T32-AI07419] Funding Source: Medline

Ask authors/readers for more resources

Viruses have evolved elaborate mechanisms to target many aspects of the host's immune response. The cytokine IFN-gamma plays a central role in resistance of the host to infection via direct antiviral effects as well as modulation of the immune response. In this study, we demonstrate that the Epstein-Barr virus (EBV) immediate-early protein, BZLF1, inhibits the IFN-gamma signaling pathway. BZLF1 decreases the ability of IFN-gamma to activate a variety of important downstream target genes, such as IRF-1, p48, and CIITA, and prevents IFN-gamma -induced class II MHC surface expression. Additionally, BZLF1 inhibits IFN-gamma -induced STAT1 tyrosine phosphorylation and nuclear translocation. Finally, we demonstrate that BZLF1 decreases expression of the IFN-gamma receptor, suggesting a mechanism by which EBV may escape antiviral immune responses during primary infection.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available